Moolec Science (MLEC) Deferred Taxes (2023 - 2024)

Moolec Science's (MLEC) quarterly Deferred Taxes came in at $280889.0 in Q4 2024, up 219.03% year-on-year from $88045.9 in Q1 2024, and up 1103.57% quarter-over-quarter from -$27989.0 in Q3 2024.

Moolec Science (MLEC) Deferred Taxes (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Deferred Taxes across 2 years of filings, most recently posting $280889.0 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -859,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -65.30 Mn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 280,889.00
Sep 30, 2024 -27,989.00
Dec 31, 2023 -235,990.00
Sep 30, 2023 -215,291.00